Alexandria Real Estate Equities, Inc (ARE) Stock News

The Canine Project, a dog beauty and skincare brand, announced the October 15 launch of FURVIVE™ Restorative Shampoo + Conditioner + Body Wash. The all-in-one product combines Brazilian Copaiba botanical with premium skincare ingredients like Niacinamide, Hyaluronic Acid, and Argan Oil, formulated specifically for canine skin. Priced at $33 for 12 fl oz, it will be available on the company's website and Amazon.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Qfin Holdings, alleging the company misled investors by overstating business resilience while downplaying regulatory headwinds. The lawsuit covers investors who purchased QFIN securities between March 18, 2026 and August 25, 2026. The action follows Qfin's August 25, 2026 earnings report showing a 31.6% revenue decline and 76.8% net income drop year-over-year, triggering an 18.91% stock price decline. The deadline to seek lead plaintiff status is November 30, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Innventure Inc., alleging the company made false statements about Accelsius' DarkNX AI data center project and overstated 2026 revenue targets. A Morpheus Research report in May 2026 revealed the DarkNX project was fabricated with no evidence of existence. Innventure subsequently suspended its revenue guidance and removed the DarkNX project from internal bookings in August 2026, causing the stock to plummet 55%. Investors who purchased securities between November 17, 2025 and August 13, 2026 may be eligible to participate in the class action with a deadline of October 27, 2026 to seek lead plaintiff status.

A securities class action lawsuit has been filed against Honeywell Aerospace (NASDAQ: HONA) for allegedly making false and misleading statements about supplier constraints and their impact on sales, as well as failing to disclose a false Claims Act investigation related to cybersecurity compliance on government contracts. The stock fell 23.16% on August 6, 2026 following disappointing earnings, and another 2.45% on September 1, 2026 after the Justice Department announced a $2 million settlement. The deadline to seek lead plaintiff status is November 23, 2026.

A securities class action lawsuit has been filed against HDFC Bank Limited alleging that the company disguised payments as marketing expenses to pay above-market interest rates to a state-owned entity to induce deposits. The scheme allegedly involved senior management approval and violated regulations. The lawsuit covers investors who purchased HDFC Bank ADS between July 17, 2023 and May 26, 2026, with an October 12, 2026 deadline to seek lead plaintiff status.

Pomerantz LLP announced investigations into potential securities fraud at Ultragenyx Pharmaceutical, OSI Systems, and lululemon athletica. The investigation into Ultragenyx was triggered by the company's failure to meet primary endpoints in a Phase 3 clinical trial for apazunersen, resulting in a 44% stock price decline on September 3, 2026.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Centerspace's acquisition by Independence Realty Trust, Fulcrum Therapeutics' acquisition by Slate Medicines, Weave Communications' acquisition by Francisco Partners, and Personalis' acquisition by Tempus AI.

Law firm Bernstein Liebhard announced an investigation into potential breaches of fiduciary duty by directors and officers of Embecta Corp. The firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. Current shareholders who purchased shares before November 25, 2025 are encouraged to contact the firm regarding their legal rights.

Law firm Brodsky & Smith announced investigations into four merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and pay fair value to shareholders. The investigations involve Priority Technology Holdings ($8.05/share), MISTRAS Group ($20.35/share), The Baldwin Group ($32.50/share), and Utz Brands ($14.25/share).

Bernstein Liebhard LLP reminds Innventure, Inc. investors of the October 27, 2026 deadline to join a securities fraud class action lawsuit. The lawsuit alleges that Innventure made materially false and misleading statements regarding its business operations, growth prospects, and financial stability, causing securities to trade at artificially inflated prices. Investors who purchased shares between November 17, 2025 and August 13, 2026 may be eligible to participate.

Bernstein Liebhard LLP has announced securities fraud class action lawsuits against three companies: AST SpaceMobile (ASTS) for investors who purchased shares between March 4, 2025 and July 15, 2026; Baidu (BIDU) for shareholders between November 18, 2025 and August 17, 2026; and Lincoln Educational Services (LINC) for shareholders between May 11, 2026 and August 9, 2026. The lawsuits allege materially false and misleading statements regarding business operations, growth prospects, and financial stability, resulting in artificially inflated stock prices and investor losses.

Bernstein Liebhard LLP has filed securities fraud class action lawsuits against Baidu, Inc., AST SpaceMobile, Inc., and Lincoln Educational Services Corporation. The lawsuits allege that defendants made materially false and misleading statements regarding business operations, growth prospects, and financial stability, causing investors to suffer significant losses when the truth was disclosed.

Beta Bionics, Inc. faces a securities fraud lawsuit for allegedly misleading investors about the safety of its iLet Bionic Pancreas device. The company downplayed FDA concerns about over 18,000 unreported complaints, characterizing them as 'benign' while the FDA warning letter later contradicted these claims. The stock fell from $31.99 to under $13 per share between July 2025 and February 2026. Eligible investors who purchased shares during this period may recover losses.

Monteverde & Associates PC is investigating four major merger and acquisition deals to determine if they are fair to shareholders: Auddia's merger with McCarthy Finney (1:1 stock exchange), Bio-Techne's sale to Merck KGaA ($73/share), Caesars Entertainment's sale to Fertitta Gaming ($31/share plus ticking consideration), and Colony Bankcorp's merger with First Reliance Bancshares ($19.75 cash or 0.94 stock exchange).

Monteverde & Associates PC is investigating four merger transactions to determine if shareholders are receiving fair value. The investigations cover Iridium Communications' sale to Rocket Lab, VerifyMe's merger with Open World Ltd, Valaris' sale to Transocean Ltd, and Standard Biotools' merger with Treeline Biosciences. The firm is offering free consultations to shareholders with concerns about these deals.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).

Kirby McInerney LLP has filed securities fraud class action lawsuits against Taboola.com Ltd., Innventure, Inc., and GoDaddy Inc. on behalf of investors who suffered losses. Taboola's stock fell 27.41% after the company disclosed it was aggressively exiting low-quality publisher relationships and cutting full-year guidance. Investors have until October 20-27, 2026 to request lead plaintiff appointment.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Innventure, Inc. on behalf of investors who purchased securities between November 17, 2025 and August 13, 2026. The lawsuit alleges that Innventure made materially false statements regarding a transformative deal with DarkNX for an AI data center in Ontario, Canada, and overstated revenue and cash flow targets for its subsidiary Accelsius Holdings LLC. Following a May 28, 2026 Morpheus Research report questioning the deal's existence, and Innventure's August 13, 2026 disclosure that the deployment site was no longer available, the stock price fell 55% to $1.62 per share. The deadline to request lead plaintiff appointment is October 27, 2026.

Kirby McInerney LLP has filed securities fraud class action lawsuits against GoDaddy Inc., Taboola.com Ltd., and Innventure, Inc. on behalf of investors. The GoDaddy lawsuit alleges the company failed to disclose that a $4.99 promotional pricing strategy for one-year domain contracts would materially impact bookings growth, which fell to 5% in Q4 2025, causing the stock to drop 14% on February 24, 2026. Investors have until October 20-27, 2026 to request lead plaintiff appointment.

Ferrari N.V. has completed its €250 million second tranche of share buybacks, purchasing 815,739 common shares across Euronext Milan and NYSE for €249.999 million. The company announced a third tranche of up to €250 million starting September 2, 2026, to be executed through non-discretionary agreements with primary financial institutions. Since January 2026, Ferrari has repurchased 1,701,184 shares totaling €510.76 million as part of its €3.5 billion multi-year buyback program expected to conclude by 2030.

A class action lawsuit has been filed against Hyliion Holdings Corp. alleging the company made materially false and misleading statements about its VFG Holdings partnership. Following a critical research report on June 23, 2026, Hyliion's stock price declined 17% in one day and another 19% the following day. Investors who purchased stock between May 12 and June 23, 2026 can join the lawsuit with a lead plaintiff deadline of October 27, 2026.

Klépierre, Europe's leading shopping mall operator, has raised its full-year 2026 guidance with EBITDA expected to reach a minimum of €1,150 million. The company demonstrated strong execution in a dynamic retail market, driving organic growth. As of July 31, 2026, the company had 286.86 million shares outstanding.

Kirby McInerney LLP is investigating Jefferies Financial Group for potential securities law violations related to alleged misleading disclosures about the company's exposure to First Brands Group, a bankrupt auto-parts supplier, through its asset-management unit Point Bonita Capital. The SEC is reportedly investigating claims that Jefferies misled investors, with Point Bonita funds owed approximately $715 million from companies that purchased First Brands' parts. Jefferies disclosed a $30 million loss tied to First Brands' collapse, and the stock declined 9% on the news.

Law firm Levi & Korsinsky has filed a class action lawsuit against ARS Pharmaceuticals for allegedly making false and misleading statements regarding expanded insurance coverage for its drug neffy through CVS Caremark. The company failed to meet its July 1, 2026 deadline for coverage expansion, causing the stock to plummet 23.9% on June 25, 2026. Investors who purchased securities between March 9 and June 24, 2026 can join the lawsuit with a lead plaintiff deadline of October 5, 2026.

Class action law firm Monteverde & Associates PC is investigating four merger and acquisition transactions: Planet 13 Holdings' merger with Vireo Growth, Olin Corporation's merger with Huntsman Corporation, and First Seacoast Bancorp's sale to Cambridge Financial Group. The firm is encouraging shareholders to contact them regarding potential concerns with these deals.

Bernstein Liebhard LLP announced an investigation into potential breaches of fiduciary duty by directors and officers of Gartner, Inc. The law firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. The investigation targets shareholders who purchased shares before February 24, 2025.

Bernstein Liebhard LLP has launched investigations into potential breaches of fiduciary duty by directors and officers at CarMax, Inc., Capricor Therapeutics, Inc., and Calix, Inc. The firm is seeking to determine whether company leadership acted in shareholders' best interests and is encouraging affected shareholders to contact them for legal consultation.

Bernstein Liebhard LLP, an investor rights law firm, has announced investigations into potential breaches of fiduciary duty by directors and officers at AeroVironment, Capricor Therapeutics, and Calix. The firm is seeking to determine whether company leadership fulfilled obligations to shareholders and whether legal remedies may be available. Current shareholders are encouraged to contact the firm for consultation.

Bernstein Liebhard LLP announced an investigation into potential breaches of fiduciary duty by directors and officers of Calix, Inc. The law firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. The investigation focuses on shareholders who purchased shares before January 28, 2026.

VINCI, a French public limited company, disclosed its capital structure as of 31 July 2026, with 587,033,654 total shares and €1,467,584,135.00 in share capital. The company announced the implementation of its share buyback programme through a share purchase agreement signed with an investment partner.